The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial
科研成果: 期刊稿件 › 文章 › 同行评审
1041
引用
（Scopus）